GlassScriptPhysician profile
Larissa M Schmidt
NPI 1801148093
$7,865.00
in general payments reported to CMS, 2019-2025
25 companies · $428 in 2025
The $428 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,358 · 2020: $1,203 · 2021: $315 · 2022: $818 · 2023: $305 · 2024: $1,439 · 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,134 · Travel and Lodging: $1,038.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,134.06 |
| Travel and Lodging | $1,038.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,030.41 | 2019-2020 | |
| Stryker Corporation | $1,471.55 | 2021-2024 | Prostep, Ortholoc 3di, Citrefix |
| Reel Surgical, INC. | $832.09 | 2020-2025 | |
| Smith+Nephew, INC. | $476.47 | 2019-2024 | Renasys Go V2 Home, Collagenase Santyl |
| In2bones USA, LLC | $268.50 | 2019-2022 | |
| Paragon 28, INC. | $256.63 | 2019-2023 | Silverback |
| Orthofix Medical, INC. | $209.86 | 2019-2025 | Physio-Stim |
| Depuy Synthes Sales INC. | $188.07 | 2022 | |
| Horizon Therapeutics Plc | $155.67 | 2021 | |
| Averitas Pharma INC. | $139.16 | 2025 | Qutenza |
| Linvatec Corporation | $137.20 | 2025 | Neospan, Biobrace 23mm |
| Integra Lifesciences Corporation | $133.21 | 2019-2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $129.62 | 2022-2025 | Jublia, Arazlo, Duobrii |
| Paratek Pharmaceuticals, INC. | $108.77 | 2022 | |
| Treace Medical Concepts, INC. | $89.67 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biowound Solutions, INC. | $39.47 | 2025 | Bio-Connekt |
| Osiris Therapeutics INC. | $38.47 | 2019 | |
| Davol INC. | $26.08 | 2023 | |
| Next Science LLC | $22.71 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $20.66 | 2025 | Exparel |
| Organogenesis INC. | $19.98 | 2022 | |
| Ermi LLC | $19.04 | 2019 | |
| Kerecis Limited | $18.71 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Axogen | $17.48 | 2019 | |
| Zimvie INC. | $15.52 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larissa Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.